 Connection
Allison Wheeler to Clinical Trials as Topic
This is a "connection" page, showing publications Allison Wheeler has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.361 |
|
|
|
-
Kuaban A, Croker AK, Keefer J, Valentino LA, Bierer BE, Boateng S, DiMichele D, Fogarty P, Gibson CM, Hood AM, Hubbard L, Isgrò A, Knobe K, Lake L, Martin I, Reid M, Roberts JC, Tomlinson W, Tunji-Ajayi L, Van Spall HGC, Voltz-Girolt C, Wheeler AP, Mast AE, Seremetis S. The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative. Blood Adv. 2025 Feb 25; 9(4):687-695.
Score: 0.155
-
Croteau SE, Wang M, Wheeler AP. 2021 clinical trials update: Innovations in hemophilia therapy. Am J Hematol. 2021 01; 96(1):128-144.
Score: 0.115
-
Jiang D, Wang M, Wheeler AP, Croteau SE. 2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders. Am J Hematol. 2025 04; 100(4):666-684.
Score: 0.039
-
Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Eichler H, Jiménez-Yuste V, Kavakli K, Matsushita T, Poulsen LH, Wheeler AP, Young G, Zupancic-?alek S, Oldenburg J, Chowdary P. Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors. Blood Adv. 2022 06 14; 6(11):3422-3432.
Score: 0.032
-
Wheeler AP, Bernard GR. Applications of molecular biology and biotechnology: antibody therapy of sepsis. J Crit Care. 1996 Jun; 11(2):77-94.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|